OP Asset Management
NKTR icon

OP Asset Management’s Nektar Therapeutics NKTR Stock Holding History

OP Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-8,333
Closed -$582K – 796
2026
Q2 		$582K Buy
8,333
+4,342
+109% +$318K 0.01% 649
2026
Q1 		$287K Buy
+3,991
New +$227K ﹤0.01% 714

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Prosight Management
Prosight Management Dallas, Texas $515M AUM 2.95% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

OP Asset Management's NKTR Position: Q3 2026 in Review

OP Asset Management sold out of Nektar Therapeutics (NKTR) in Q3 2026, closing a stake of 8,333 shares — an estimated $582K sold.

OP Asset Management first reported a position in NKTR in Q1 2026 and held it in 2 quarters. The position peaked at $582K in Q2 2026. 168 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.

  • OP Asset Management reported no remaining Nektar Therapeutics position as of Q3 2026 after selling out during the quarter.
  • OP Asset Management sold 8,333 Nektar Therapeutics shares in Q3 2026, an estimated $582K.
  • OP Asset Management first reported a position in Nektar Therapeutics in Q1 2026 and held it in 2 quarters.
  • OP Asset Management's Nektar Therapeutics position peaked at $582K in Q2 2026.
  • 168 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.

Based on OP Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.